Evidence-based complementary treatment of pancreatic cancer: a review of adjunct therapies including paricalcitol, hydroxychloroquine, intravenous vitamin C, statins, metformin, curcumin, and aspirin
Stephen Bigelsen Department of Allergy, Asthma and Immunology, Rutgers New Jersey Medical School, Newark, NJ, USA Abstract: Despite new and exciting research and renewed optimism about future therapy, current statistics of survival from pancreatic cancer remains dismal. Patients seeking alternative...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-07-01
|
| Series: | Cancer Management and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/evidence-based-complementary-treatment-of-pancreatic-cancer-a-review-o-peer-reviewed-article-CMAR |